← Scroll for more →
Incyte Corp (INCY)
Services-Commercial Physical & Biological Research
Latest Price
$120.39
TTM P/E
64.04
Normalized P/E
43.97
TTM Div Yield
--
Fwd Div Yield
--
Book Value
27.84
P/B Ratio
4.32
Valuation metrics
adjust assumptions →EPS: $6.41
Book value / share: $26.04
Formula: √(22.5 × EPS × BVPS)
Graham Number
$61.28
49% downside
Norm. op. income: $579M (median of 7yr)
Tax rate: 26%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$38.79
68% downside
Base FCF: $568M (median of recent 5yr)
Growth: 5%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$65.89
45% downside
EPS: $6.41
Target P/E: 44×
Formula: EPS × P/E
P/E Fair Value
$282.04
+134% upside
Institutional Ownership
97.6% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 30.76M | $3.49B | 15.08% | +17.9K | 2026-06-30 |
| BlackRock, Inc. | 18.03M | $2.04B | 8.84% | -945.5K | 2026-06-30 |
| Dodge & Cox | 11.96M | $1.35B | 5.86% | -295.0K | 2026-06-30 |
| Vanguard Capital Management LLC | 11.02M | $1.25B | 5.40% | +94.2K | 2026-06-30 |
| State Street Corp | 9.72M | $1.10B | 4.77% | +81.0K | 2026-06-30 |
| Vanguard Portfolio Management LLC | 7.79M | $883.0M | 3.82% | +31.9K | 2026-06-30 |
| AQR Capital Management LLC | 5.32M | $603.0M | 2.61% | -487.0K | 2026-06-30 |
| Geode Capital Management, LLC | 4.75M | $536.0M | 2.33% | +47.6K | 2026-06-30 |
| Lsv Asset Management | 4.12M | $467.0M | 2.02% | +203.7K | 2026-06-30 |
| Invesco Ltd. | 4.08M | $462.0M | 2.00% | +209.7K | 2026-06-30 |